Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 842 across all filing types
Latest filing 2025-12-23 Share Issue/Capital Cha…
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - BXN 7 pages 20.7KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an official announcement from BIOXYNE LIMITED regarding the application for quotation of 30,000,000 ordinary fully paid shares issued under an employee incentive scheme. It details the securities to be quoted, issue dates, and related information about the securities and key management personnel involved. The document is a formal application to the ASX for listing these securities and does not contain financial statements, earnings data, or management discussion. It is not a report but an announcement related to capital changes and securities quotation. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is 6463 characters, which is sufficient to provide substantive details about the securities issue rather than a brief notice or report publication announcement.
2025-12-23 English
Notification regarding unquoted securities - BXN 6 pages 19.0KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of unquoted securities under an employee incentive scheme. It includes specifics such as the number of securities issued, dates, and mentions key management personnel receiving securities. The document is a formal notification to the ASX about a securities issue, not a financial report or earnings release. It fits the category of announcements regarding new share issues or capital changes. Therefore, it aligns with the 'Share Issue/Capital Change' category (SHA). The document length and content confirm it is a full notification rather than a brief announcement or a report publication notice.
2025-12-23 English
Change of Directors Interest Notice X 2 4 pages 261.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings and interests of company directors, including number of shares held before and after changes, nature of interests, and dates of changes. The document is a formal notification of personal share transactions by company directors. There is no financial performance data, earnings information, or report publication content. This matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document length is 7703 characters, sufficient for detailed disclosure but not a full financial report. Therefore, the correct classification is DIRS.
2025-12-23 English
Notification regarding unquoted securities - BXN 5 pages 16.7KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of unquoted securities by BIOXYNE LIMITED. It includes specifics such as the number of securities issued, issue dates, and references to previous announcements (Appendix 3B). The content is focused on notifying the market about the issuance of securities, which aligns with announcements related to share issues or capital changes. There is no financial performance data, management discussion, or audit information present. The document is a formal notification of a capital change event rather than a report or presentation. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and detail support a confident classification.
2025-12-17 English
Application for quotation of securities - BXN 6 pages 19.1KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX. It details the issuance of new shares in lieu of cash payment for services rendered, including the number of securities, issue date, and compliance with listing rules. This type of document is a formal announcement related to capital changes, specifically the issuance and quotation of new shares. It is not a financial report, earnings release, or management discussion. Therefore, it fits the category of Share Issue/Capital Change announcements.
2025-12-14 English
Application for quotation of securities - BXN 6 pages 19.6KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an official announcement from BIOXYNE LIMITED regarding the application for quotation of new securities on the ASX. It details the number and type of securities to be quoted, issue dates, approval dates, and compliance with listing rules. The content focuses on the issuance and quotation of shares, including details about directors participating in a capital raise and shareholder approval. This matches the definition of a Share Issue/Capital Change announcement, which covers new share issues and capital changes. The document is not a full financial report, earnings release, or management discussion, but a regulatory announcement about securities quotation and capital changes.
2025-12-14 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.